School-Based Assessment of Micronutrient Interventions in Adolescents in Burkina Faso (SAMIA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04657640 |
Recruitment Status :
Active, not recruiting
First Posted : December 8, 2020
Last Update Posted : October 18, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Anemia | Dietary Supplement: Iron and folic acid (IFA) Dietary Supplement: Multiple Micronutrient Supplements (MMS) and loading dose of Iron and Folic Acid (IFA) | Phase 3 |
This study aims to implement and evaluate micronutrient supplementation interventions to improve adolescent nutrition, health and education in Burkina Faso. Findings from this study will clarify the optimal supplementation strategy (iron and folic acid alone or adding other essential nutrients) and provide a basis for scale up of national micronutrient supplementation programs to benefit the adolescent population as a whole in Burkina Faso.
This will be a cluster randomized study with 3 arms. 42 schools per country will be enrolled (14 schools per arm) to receive either 1) daily Multiple Micronutrient Supplements (MMS) and weekly Iron and Folic Acid (IFA) for the first 5 weeks and daily MMS for the remainder of the study; or 2) weekly IFA; or 3) to serve as controls. As recommended by the World Health Organization in settings where continuous supplementation is not possible, supplementation will be intermittent. Supplementation will be provided for 3 months, stopped for 3 months over the school summer holidays and resumed for 3 months once students return to school after the holiday. Students in intervention schools will receive supplementation and students in control schools will receive the usual care (which does not include supplementation but does include existing curriculum on nutrition and water, sanitation and hygiene [WASH]). The program will be evaluated comparing effects of weekly IFA and daily MMS on anemia status and school attendance/retention.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 2100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Schools will be randomly assigned to weekly iron and folic acid (IFA) supplementation; daily multiple micronutrient supplements (MMS); or control. |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Scaling-up High-impact Micronutrient Supplementation Interventions to Improve Adolescents' Nutrition and Health in Burkina Faso |
Actual Study Start Date : | December 11, 2020 |
Estimated Primary Completion Date : | May 31, 2023 |
Estimated Study Completion Date : | May 31, 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: weekly iron and folic acid supplementation (IFA) |
Dietary Supplement: Iron and folic acid (IFA)
Weekly regimen of one tablet containing Iron (60mg) and Folic Acid (2800 μg) for 3 months intermittently |
Experimental: daily multiple micronutrient supplement (MMS) |
Dietary Supplement: Multiple Micronutrient Supplements (MMS) and loading dose of Iron and Folic Acid (IFA)
Daily regimen of MMS for 3 months intermittently. MMS is the United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP) tablet containing fifteen micronutrients including iron (30mg), folic acid (400 mcg), Vit A, Retinol (800 RE), vit D (200 IU), vit E (10 mg), vit C (70 mg), vit B1 (1.4 mg), vit B2 (1.4 mg), vit B6 (1.9 mg), vit B12 (2.6 mcg), niacin (18 mg), zinc (15 mg), copper (2 mg), iodine (150 mcg), selenium (65 mcg). For the first 5 weeks of the study, participants will also receive weekly regimen of one tablet containing Iron (60mg) and Folic Acid (2800 μg) as a loading dose, in addition to daily MMS. |
No Intervention: control |
- Anemia Status [ Time Frame: Up to one year ]Anemia will be defined as hemoglobin level <10 g/dL
- School attendance [ Time Frame: Up to one year ]School attendance will be measured as number of days of missed school per student
- School retention [ Time Frame: Up to one year ]School retention will be measured as number of students who drop out of school

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 10 Years to 17 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Adolescents aged 10-17 years
- Enrolled in secondary school form 1 at study initiation
- Member of one of the selected classes in a participating school
- Consent provided by the parent
- Assent provided by the adolescent
- Fluency in French
Exclusion Criteria:
- No informed consent from parent or assent from adolescent
- Self-reported Pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04657640
Burkina Faso | |
Nouna Health Research Center | |
Nouna, Burkina Faso |
Principal Investigator: | Wafaie W Wafaie, MBBS, MPH, MS, DrPH | Harvard School of Public Health (HSPH) |
Responsible Party: | Wafaie Fawzi, Professor of Nutrition, Epidemiology, and Global Health, Harvard School of Public Health (HSPH) |
ClinicalTrials.gov Identifier: | NCT04657640 |
Other Study ID Numbers: |
IRB20-1108 |
First Posted: | December 8, 2020 Key Record Dates |
Last Update Posted: | October 18, 2022 |
Last Verified: | October 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Multiple Micronutrient Supplementation Iron and Folic Acid Nutrition Adolescent Health |
Iron Trace Elements Folic Acid Micronutrients |
Vitamin B Complex Physiological Effects of Drugs Hematinics Vitamins |